MiNK Therapeutics, Inc.
INKT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001840229
No open-market purchases or sales by MiNK Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.39M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by MiNK Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for MiNK Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wiinberg Ulf | Director | 23,929 | Sep 2, 2026 | 4 |
| Holcomb John Bradley | Director | 4,691 | Sep 2, 2026 | 4 |
| Behner Peter | Director | 24,404 | Sep 2, 2026 | 4 |
| Ryan Barbara | Director | 23,591 | Sep 2, 2026 | 7 |
| Corvese Brian | Director | 54,770 | Sep 2, 2026 | 4 |
| Buell Jennifer | Chief Executive Officer | 57,942 | Jan 14, 2026 | 2 |
| Kadlec Robert Peter | Director | 19,126 | Dec 3, 2025 | 1 |
| van Dijk Marcus Antonius | Chief Scientific Officer | 27,363 | Jan 18, 2024 | 0 |
| Agenus Inc | 10% Owner | 21,772,863 | Oct 16, 2023 | 0 |
| Baldoni John | Director | 41,193 | Sep 6, 2023 | 0 |
| Armen Garo H | Director | 1,866,400 | May 26, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 (view filing) | Jun 4 | 1 day | Ryan BarbaraDirector | SSale | −1.50K | $12.76 | −$19.1K | −6.4%22.0K after | 2 lots |
| Mar 11, 2026 (view filing) | Mar 9-10 | 2 days | Ryan BarbaraDirector | SSale | −1.50K | $14.70 | −$22.1K | −6.8%20.4K after | 4 lots |
| Mar 4, 2026 (view filing) | Feb 27-Mar 2 | 5 daysLate | Ryan BarbaraDirector | SSale | −500 | $10.85 | −$5.43K | −2.2%21.9K after | 2 lots |
| Oct 16, 2023 (view filing) | Oct 12-16 | 4 days | Agenus Inc10% Owner | PPurchase | +23.0K | $1.10 | +$25.3K | +0.1%21.8M after | 3 lots |
| Oct 6, 2023 (view filing) | Oct 4 | 2 days | Agenus Inc10% Owner | PPurchase | +15.0K | $1.09 | +$16.4K | +0.1%21.7M after | |
| Aug 31, 2023 (view filing) | Aug 29 | 2 days | Agenus Inc10% Owner | PPurchase | +29.7K | $1.52 | +$45.1K | +0.1%21.7M after | |
| Aug 28, 2023 (view filing) | Aug 24-28 | 4 days | Agenus Inc10% Owner | PPurchase | +183.1K | $1.53 | +$280.7K | +0.9%21.7M after | 2 lots |
| May 12, 2023 (view filing) | May 10-11 | 2 days | Agenus Inc10% Owner | PPurchase | +45.4K | $1.47 | +$66.7K | +0.2%21.6M after | 2 lots |
| May 5, 2023 (view filing) | May 5 | Same day | Armen Garo HDirector | SSale | −100.0K | $0.95 | −$95.0K | −5.1%1.87M after | From original |
| May 5, 2023 (view filing) | May 3-5 | 2 days | Agenus Inc10% Owner | PPurchase | +250.4K | $1.04 | +$260.4K | +1.2%21.6M after | From original4 lots |
| May 4, 2023 (view filing) | May 2 | 2 days | Armen Garo HDirector | PPurchase | +100.0K | $0.95 | +$95.0K | +5.3%1.98M after | |
| Jul 21, 2022 (view filing) | Jul 18-19 | 3 daysLate | Wiinberg UlfDirector | PPurchase | +20.0K | $1.38 | +$27.6K | +7.2%298.3K after | 2 lots |
| Oct 20, 2021 (view filing) | Oct 19 | 1 day | Agenus Inc10% Owner | PPurchase | +1.40M | $12.00 | +$16.8M | +7.2%20.9M after |